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Sammendrag: 
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Implikasjoner for menneskers aldring, kjønn og trening. 
FORFATTER:  Steven Keita Nishiyama 
 
Mye forskning som vurderer blodstrøm i human skjelettmuskel er blitt gjennomført, 
som reaktiv hyperemi og muskelmetabolisme i isolerte muskler, men det er et relativt 
fåtall studier som har undersøkt vaskulære og metabolske forskjeller i armer og bein 
både i hvile og under metabolsk utfordrende perioder som trening og avstenging av 
blodstrøm med trykkmansjetter. Imidlertid har nylig noen spennende og klinisk 
signifikante forskjeller mellom armer og bein blitt tydeliggjort både hos friske og 
sykdomsrammede, og hos de siste synes det som om beina har en større grad av 
vaskulær dysfunksjon. For å forstå bedre vaskulær kontroll og patologi (e.g. aldring 
og perifer arteriell sykdom/ intermittent claudication) som gir utslag i større grad av 
vaskulære forskjeller, gjennomførte vi en serie protokoller som var designet for å 
evaluere skjelettmusklenes metabolske og vaskulære reguleringsmekanismer og 
implikasjonene for forskjellige grupper av befolkningen (i.e. alder og kjønn). 
 Flere nye metodologiske teknikker (ultralyd/doppler, nukleær magnetisk 
resonans (NMR) og elektron paramagnetisk resonans (EPR) ble brukt for å måle 
fysiologiske variabler (blodstrøm, reaktiv hyperemi, oxidativ metabolisme, bioenergi 
og produksjon av frie radikaler) ved bruk av eksperimentelle protokoller som 
inkluderte isolert dynamisk arbeid, kuldestimulert konstriksjon, inntak av anti-
oksidanter og bruk av trykkmansjetter for å indusere oksygenmangel. Totalt 140 
friske forsøkspersoner (122 unge (23±2 år) forsøkspersoner (105 mannlige og 17 
kvinnelige) og 18 eldre (72±2 år)  forsøkspersoner (16 mannlige og 2 kvinnelige)) 
deltok i studiene. Avhengig av eksperimentoppsett og måleteknikker ble målingene 
gjort i arm (brakiale a.) og bein (enten de femorale arteriene eller poplietal a.). Disse 
studiene ga følgende resultater: 1) det er en arbeidsindusert avhengighet av pro 
oxidant stimulert vasodilatasjon, som viser en viktig og positiv vaskulær rolle for frie 
radikaler, 2) vasokonstriksjon mediert via sympaticus uttrykkes likt både i armer og 
bein i hvile både for trente og utrente forsøkspersoner, men med forskjellig utvikling 
av vasokonstriksjon under akutt arbeid både med hensyn på arm- og beinforskjeller og 
treningsstatus, 3) leggmusklene i en ung frisk gruppe forsøkspersoner viste en svekket 
reperfusjon respons, mens arterie blodstrøms-mediert dilatasjons data paradoksalt 
viser at bein har større vaskulær reaktivitet enn arm, 4) aldring har en arm og 
beinspesifikk effekt på vaskulær struktur, reaktiv hyperemi og arbeidsindusert 
blodstrøm, og 5) uavhengig av kjønn er reaktiv hyperemi større i beina og kvinner har 
den samme vaskulære funksjon i armer, men er svekket i beina.  
 Samlet sett ser det ut til at arm- og beinforskjeller eksisterer, og i forskjellig 
grad i forskjellige deler av befolkningen. Disse studiene har belyst flere underliggende 
mekanismer som definerer forskjeller i vaskularitet, som alle er viktige for å forstå 
blodstrøm i skjelettmuskel og vaskulære kontrollmekanismer ikke bare i den friske 
delen av befolkningen, men også i sykdomsgrupper som synes å vise arm- og 
beinspesifikke vaskulære funksjonsproblemer.  

Summary: 
TITLE: Perspectives on Limb-Vascular Heterogeneity: Implications for 
Human Aging, Sex, and Exercise 
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Considerable research addressing human skeletal muscle blood flow, vascular 
reactivity, and muscle metabolism has been performed in isolated limbs, but there is a 
relative paucity of studies that have assessed limb-specific vascular and metabolic 
differences both at rest and during metabolically challenging periods such as exercise 
and cuff-ischemia. However, recently some intriguing and clinically significant 
between-limb heterogeneities have become apparent in both health and disease, in the 
latter the lower extremities exhibiting the higher degree of vascular dysfunction. To 
better understand local vascular control and the multiple pathologies (e.g. aging and 
peripheral artery disease) that exhibit limb-specific tendencies, we conducted a series 
of protocols designed to systematically evaluate vascular limb heterogeneities with 
respect to skeletal muscle metabolic and vascular regulatory mechanisms and the 
implications for differing populations (i.e. age, sex).  
Multiple novel methodological techniques (Ultrasound Doppler, Nuclear 
Magnetic Resonance (NMR), and Electron Paramagnetic Resonance (EPR)) were 
utilized to assess physiological variables (blood flow, vascular reactivity, oxidative 
metabolism, bioenergetics, and free radical generation, respectively) during 
experimental protocols which included isolated dynamic exercise, cold-pressor 
stimulation, anti-oxidant administration, and ischemic cuff-occlusion. A total of 140 
healthy subjects (122 young (23 ± 2 yrs) subjects (105 males and 17 young females) 
and 18 old (72 ± 2 yrs) subjects (16 males and 2 females)) participated in these 
studies. Dependent on experimental modality and technique, measurements were 
made in the arm (brachial artery) and leg (either the femoral arteries (common, deep, 
and superficial) or popliteal artery). These studies revealed the following results: 1) 
There is an exercise-induced reliance upon pro-oxidant stimulated vasodilation 
thereby revealing an important and positive vascular role for free radicals, 2) 
Sympathetically mediated vasoconstriction is expressed equally and globally at rest in 
both sedentary and trained individuals, with a differential pattern of vasoconstriction 
during acute exercise according to limb and exercise training status, 3) The lower legs 
in a young healthy group of human subjects exhibit an attenuated ischemic 
reperfusion response, while conduit artery flow-mediated dilation data paradoxically 
reveal that the lower legs have greater vascular reactivity that the arm, 4) Aging has a 
limb-specific effect on vascular structure, vascular reactivity, and exercise-induced 
blood flow, and 5) Regardless of sex, vascular reactivity is greater in the legs and 
women have similar vascular function in the upper extremities, but this is attenuated 
in the lower extremities. 
Collectively, inherent limb differences appear to exist, and to different extents 
in varied populations. These studies have elucidated several underlying mechanisms 
defining vascular heterogeneities, all of which are important for understanding 
skeletal muscle blood flow and vascular control mechanisms in not only a healthy 
population, but also in diseased populations that tend to exhibit limb-specific vascular 
dysfunction.  
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INTRODUCTION 
VASCULAR CONTROL MECHANISMS 
Central and Local Mechanisms Governing Vascular Function and Muscle Blood Flow 
The human vasculature is a complex, dynamic system which precisely regulates the 
delivery of blood to all regions of the body. Regulation of these vascular responses involves 
the coordination of various central and local mechanisms all of which exist and act to 
successfully match the supply of blood with the metabolic demand of various tissues under 
wide-ranging conditions (91, 107). Blood flow is principally dictated by the product of vessel 
diameter and blood velocity, thus, the degree of vascular tone as well as the impact of 
controlling blood velocity are key determinants of blood flow. Accordingly, central and local 
factors act together to vary 1) the degree of vascular smooth muscle “tone”, which ultimately 
determines the diameter of the blood vessel, and 2) the arterial pulse pressure, which 
ultimately determines the velocity of the blood. The central control mechanisms consist 
primarily of neuronal and hormonal factors, and are responsible for regulating cardiac 
activity and regional vascular tone. As such, the central mechanisms are designed for the 
maintenance of systemic blood pressure and central cardiovascular homeostasis. Equally as 
important, vascular control is also regulated by local factors such as autocrine and paracrine 
substances, metabolic bi-products, and mechanical stimuli such as shear stress (80). In 
contrast to the central mechanisms, local vascular control mechanisms are designed to 
maintain site-specific vascular homeostasis. 
Hormonal factors can influence vascular tone in skeletal muscle, but they appear not 
to be of foremost importance in vascular control, particularly during a dynamic challenge 
such as exercise. However, nervous regulation by the autonomic nervous system controls 
both the central (e.g. heart) and peripheral (e.g. vascular resistance and conductance) 
mediators of the circulation and is of paramount importance in acute vascular control (20, 
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50). The combination of signals from central motor systems and by peripheral sensors (e.g. 
baroreceptors, muscle chemosensors, and mechanoreceptors) being integrated by the central 
nervous system (CNS) provides a major feed-forward and feed-back system with a high 
degree of specificity (171). By altering efferent outflow of the sympathetic and 
parasympathetic system, CNS nervous activity subsequently influences heart rate, cardiac 
output, and vascular tone, and thus, blood flow.  
Vascular function is also influenced by local mechanisms that specifically regulate 
vascular tone in a localized area. Two principal local mechanisms are the metabolic 
vasoactive milieu and vascular myogenic activity (37). The metabolic vasoactive milieu  
consists primarily of mediators from the vascular endothelium and muscle fibers (e.g. 
adenosine, nitric oxide (NO), oxidative stress), acting through pharmaco-mechanical coupling 
to promote vascular contraction or relaxation (107). Vascular smooth muscle is also 
controlled by an inherent constriction in response to stretch, normalizing changes in pressure 
across the vessel wall, the myogenic response (90). 
Collectively, both central and local systems govern vasomotion through 
vasoconstrictor and vasodilator processes and thus regulate the circulation of blood in an 
elegant and dynamic fashion. However, details regarding this interaction between local 
metabolic and systemic vascular control mechanisms, as well as the limb-specific variation 
that occurs in healthy young and senescent populations are certainly not well understood.  
 
Vascular Endothelial Function and Shear Stress 
In 1980 Furchgott and Zawadzki discovered the role of the vascular endothelium as a 
modulator and initiator of vasomotion, forever changing the landscape of vascular biology 
(62). Previously characterized as simply a physical barrier between the blood and the vascular 
wall, the vascular endothelium is the monolayer of cells lining all of the blood vessels in the 
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body that responds to both chemical and physical stimuli and forms an important component 
of local vascular regulation and vascular health (204). In a non-diseased/ healthy state, the 
endothelium releases a balance of autocrine and paracrine substances that modulate vascular 
tone and permeability, as well as angiogenesis and inflammation (55). Endothelial function is 
therefore an essential component to vascular homeostasis and control. Conversely, 
endothelial dysfunction is associated with the disruption in this delicate balance, adopting a 
phenotype that facilitates inflammation, thrombosis, vasoconstriction, and atherosclerotic 
lesion formation (113). Furthermore, the present body of knowledge supports the notion that 
endothelial function has prognostic value for cardiovascular risk, indicating that endothelial 
dysfunction plays a significant role in the development and progression of vascular pathology 
(21, 204). 
 One of the most important stimuli for the release of endothelial-derived factors is 
blood flow-associated shear stress (144). The endothelial response to shear stress includes 
changes in ionic conductance and the production of vasoactive molecules. This is followed by 
continuing signaling cascades and transcription factor activation, protein synthesis, and 
finally structural changes to alleviate the elevated shear stress (33). Shear stress refers to the 
laminar frictional force exerted by the blood as it moves along the vessel wall and is 
represented by the equation: ηV/D (where η = blood viscosity, V= blood flow velocity and D 
= vessel diameter) (64). A shear stress stimulus under experimental conditions, typically an 
elevation in blood flow, is created by decreasing downstream vascular resistance so that flow 
through the feeding conduit artery is increased. A reduction in downstream vascular 
resistance can be achieved in several ways and the method employed determines the profile 
of the shear stress stimulus in the conduit artery. The technique predominantly used in 
eliciting this response was first described and employed by Celermajer et al. (21), where a 
pneumatic cuff is placed around a limb and inflated suprasystolically to induce an ischemic 
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environment  distal to that cuff. Following a specific amount of time, the cuff is released and 
the transient elevation in blood flow-associated shear stress induces a vasodilatory response. 
This response is termed endothelial-dependent flow-mediated vasodilation (FMD). In vitro 
experiments have shown that any change in artery wall shear stress stimulates the endothelial 
cells to synthesize and release vasoactive substances: increases in shear stress cause the 
release of vasodilators such as NO, prostacyclin (PGI2), and endothelial-derived 
hyperpolarizing factor (EDHF) (29, 59, 132), while decreases in shear stress cause the release 
of endothelin-1, a potent vasoconstrictor (99). Under very specific procedural conditions, 
FMD examined through the cuff-occlusion modality has since been shown to elicit strictly a 
NO-dependent endothelial-mediated response (47, 125).  NO is synthesized within the 
endothelium from L-arginine under the influence of the enzyme endothelial nitric oxide 
synthase (eNOS). NO has anti-inflammatory and antithrombotic effects and therefore 
provides a degree of vasoprotection (28, 55). The goal of many human conduit artery FMD 
studies is to create a shear stress stimulus that evokes a NO dependent FMD response that can 
provide an assay of NO bioavailability and NO associated vasoprotection (103). To that end, 
FMD has emerged as a broadly applicable, non-invasive clinically relevant research tool that 
allows the assessment of endothelium-dependent peripheral artery vasomotion (22, 57, 195).  
 
The Autonomic Nervous System 
One of the primary means through which the autonomic nervous system regulates vascular 
tone and subsequently blood flow is through sympathetic nerve activity (SNA). Exercise 
leads to an increase in global SNA which affects both the heart (increasing frequency and 
strength of cardiac muscle contraction) and the blood vessels (producing vasoconstriction). 
Vasoconstriction is achieved through the release of norepinephrine (NE), which binds to 
membrane-bound post-junctional α-adrenergic receptors on the vascular smooth muscle. In 
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the vasculature of exercising muscle, these α-adrenergic receptors are susceptible to the 
metabolic byproducts originating from the active muscle tissue causing the vascular smooth 
muscle to be less sensitive to catecholamines (74, 169), and thus, attenuating 
vasoconstriction. Remensynder et al. (158) coined this phenomenon as “functional 
sympatholysis” and ever since, there is accumulating evidence from both animal and human 
studies supporting this attenuation of sympathetically-mediated vasoconstriction in exercising 
skeletal muscle (18, 197, 213). Nevertheless, the underlying mechanisms of sympatholysis 
are not completely understood, and remain a topic of many ongoing investigations. 
 
Oxidative Stress and Vascular Control 
Superoxide anion (O2-) and other free radicals are highly energized molecular species, 
structurally distinct in that they contain one or more unpaired electrons in their atomic orbital 
(71). Within all mammalian tissue oxidative phophorylation and the formation of ATP is 
accompanied by the univalent reduction of O2 to produce O2- at an estimated rate of between 
2-5% (16, 56). This “electron leakage” is thought to occur at the NADH dehydrogenase (200) 
and the ubiquinone cytochrome-bc segment of complex III (150) in the mitochondrial 
electron transport chain. Free radicals are also generated by various oxidases, such as 
xanthine oxidase, cyclooxygenase, nitric oxide synthase, cytochrome P450, and the Nox 
family of NAD(P)H oxidases (210).  
Oxidative stress is ultimately determined by the balance between pro and antioxidant 
forces. In low concentrations, free radicals are thought to act as mediators and modulators of 
cell signaling and contribute to other key functions such as regulating the activity of 
transcription factors and gene expression (58, 126). In contrast, high levels of free radicals in 
the vasculature can exceed the local antioxidant defense capacity and thus induce oxidative 
stress in arterial cells and has been associated with hypertension, atherosclerosis, diabetes, 
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heart failure, sepsis, as well as the aging process (203). Since the initial observation that 
superoxide (O2-) and other free radicals inactivate NO (208) it has become increasingly 
apparent that this may contribute to the origin and progression of vascular dysfunction in 
many of these pathologies (56, 194). Such conclusions are supported by the improvement in 
endothelial function afforded by the infusion of high levels of exogenous antioxidants in 
these conditions (54, 116). With the wide ranging impact of oxidative stress in disease and 
disease progression there is a clear need to better understand the role of free radicals and 
antioxidants in terms of healthy vascular function. 
 
VASCULAR ADAPTATIONS AND ALTERATIONS       
Age-Associated Changes in Vascular Structure and Function 
Aging is a relatively non-specific word; in humans, it is particularly difficult to 
differentiate between manifestations of aging per se and symptoms of disease and disease 
progression. Rather, it has become increasingly apparent that age-associated changes in 
cardiovascular structure and function become partners with pathophysiological disease, 
where aging blood vessels provide the milieu in which disease can flourish. However, over 
time the human cardiovascular system undergoes many deleterious adaptations, and 
advancing age has therefore been proposed as a major risk factor for cardiovascular disease, 
diabetes, hypertension, stroke, atherosclerosis, and congestive heart failure (101). As humans 
age, changes occur in both the central and peripheral circulation that can affect compliance in 
arteries and arterioles, arterial blood pressure, and ultimately limit the dynamic capacity of 
the vasculature (10, 206). Previous studies have documented several factors that 
preferentially occur in aging populations, including arterial wall thickening (41, 81, 135) and 
arterial stiffening (95), insulin resistance (119), and increased α-adrenergic (40, 180) and 
endothelin-1-mediated vasoconstriction (193). However, at the forefront of several functional 
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investigations has been the age-related reduction in endothelial function affecting vascular 
tone (17, 205). This is particularly associated with an attenuated NO regulation by the 
progressive attenuation in eNOS expression, impairment of the nitric oxide pathway, and 
elevated oxidative stress (2, 7, 184, 194). However, the mechanisms involved in this 
alteration as well as the extent of these changes are not well defined and probably depend 
upon the specific etiology. 
 
The Influence of Sex on Vascular Reactivity 
The incidence of cardiovascular disease differs significantly between men and 
women. This is thought to be predominantly due to sex-specific differences in risk factors 
and the hormonal milieu. Indeed, epidemiological studies have revealed that atherosclerosis, 
hypertension, peripheral vascular and coronary artery diseases occur with greater prevalence 
in males and in postmenopausal women when compared to premenopausal females (8, 100, 
111). While in clinical assessments of endothelium-dependent peripheral artery vasomotion, 
FMD studies of healthy populations have revealed that the brachial artery (BA) FMD is more 
pronounced in premenopausal women than men and their postmenopausal counterparts (112, 
142, 176). Therefore, previous studies have implicated estrogen as both a prostaglandin 
promoter and an antioxidant, protecting nitric oxide from degradation and facilitating 
increased vasomotion (117, 140). Thus, current thinking knowledge suggests female sex 
hormones, such as estrogen, have positive vascular effects, whereas their absence could be 
related to vascular dysfunction and subsequent atherogenic disease states. However, in 
studies assessing flow-mediated dilation, when the initial value of arterial diameter is taken 
into consideration, the increase in diameter appears similar between males and females (89). 
This suggests that some of the documented sex differences in vascular reactivity could be the 
13 
 
consequence of a mathematical bias rather than the beneficial effects of the female hormonal 
milieu.  
 
Vascular Effects of Exercise Training  
It has been well documented and accepted that habitual exercise not only preserves 
vascular homeostatic mechanisms, but also restores perturbed vascular mechanisms back 
towards the normal physiological range. Exercise training is associated with an improvement 
of many cardiovascular and autonomic parameters (9, 14, 77, 84), which are viewed as 
beneficial adaptations to the physiologic demands of the activity. Elevations in maximal 
oxygen consumption ( o2max), a hallmark feature of exercise training, have been attributed to 
both increases in maximal cardiac output and heightened extraction of oxygen from the 
arterial blood (25, 107). The beneficial effects of exercise training specifically on the 
vasculature can be grouped into two forms: structural vascular adaptations and functional 
vascular adaptations. Structural changes are generally characterized by vascular remodeling 
(i.e. growth of already-existing vessels) (43, 69) and angiogenesis (15). Functional 
adaptations are characterized by less neurogenic vasoconstrictor tone (171) and altered local 
control mechanisms via changes in metabolic control systems (38, 105). Exercise training can 
augment endothelium-dependent vasodilation by enhancing eNOS expression and therefore 
increasing NO bioavailability (72). It is also possible that enhanced endothelial function with 
exercise training is the consequence of a prolonged half-life of NO by reducing its 
degradation by free radicals or by directly decreasing free radical production (61) 
Specific to this thesis are the autonomic adaptations that occur with exercise training. 
Data in animal models are equivocal regarding the effect of exercise training on limb α-
adrenergic responsiveness. In rats, longitudinal training studies have demonstrated decreased 
sensitivity to sympathomimetics in the trained muscle (209) and no change (52) or decreased 
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sensitivity (188) in isolated arterial segments. In humans, to our knowledge only two studies 
have assessed the effect of exercise training on α-adrenoreceptor-mediated vasoconstriction. 
Smith et al. (186) observed similar changes in arm blood flow (venous plethysmography) and 
arterial blood pressure in sedentary and endurance-trained subjects in response to both 
sympathomimetic infusion and orthostatic challenge. Similarly, O’Sullivan et al. (133) 
demonstrated a similar degree of vasoconstriction in the forearm of trained and sedentary 
subjects in response to a 2-min cold-pressor test (CPT). Thus, the present study in both the 
arm and leg is an effort to extend these earlier findings and elucidate the effect of chronic 
exercise training upon sympathetically mediated vasoconstriction. 
 
PERSPECTIVES ON LIMB-VASCULAR HETEROGENEITY 
Considerable research addressing human skeletal muscle blood flow, vascular 
reactivity, and muscle metabolism has been performed in isolated limbs of both the upper and 
lower extremities, but it appears that many of these studies do not have explicit interest in the 
limb-specific physiological response. The forearm and its vasculature is a good example of a 
targeted region that has been adopted as much for its practical appeal as its physiological 
implications. For example, the location and accessibility of the forearm and its vasculature 
allow vascular reactivity and blood flow measurements to be carefully and relatively easily 
performed. This has certainly been the case in the clinical context as the development and 
application of the FMD test has become increasingly, if not almost exclusively, performed in 
the BA of the arm (31, 76, 125, 148). Indeed, a strong relationship of the BA FMD test and 
coronary vessel health has been revealed (3, 195). However, the forearm and its vasculature 
has historically been used as a model to extrapolate findings for the systemic vasculature in 
humans without the substantial evidence that this is the case (3, 177, 195). Certainly, the 
perfusion of the forearm may not be of significant consequence to the body as a whole, due to 
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its relatively small perfused muscle mass. As such, there is a relative paucity of studies that 
have assessed vascular and metabolic differences with a specific interest in investigating 
possible limb differences.  
To that end, intriguing and clinically significant between-limb heterogeneities have 
recently become apparent (128, 139, 166). Teleologically, forearm and lower leg differences 
may be explained by the effects of gravity on limb vascular structure. As upright bipeds, 
humans are regularly subjected to large hydrostatic and transmural forces in the legs that 
appear to contribute to decreased capacitance and vascular conductance in the stiffened 
resistance vessels of the leg (53, 171). The impact of this elevated pressure on vascular 
control mechanisms in the legs has not been elucidated. However, based on research 
investigating the effects of elevated blood pressure by the coarctation of the aorta, both 
endothelial and vascular smooth muscle cell homeostatic processes have been shown to be 
impaired (12, 136, 202). This model of hypertension resembles the upright condition of the 
human vasculature where mean arterial blood pressure at the ankle of humans is 
approximately 65 mm Hg higher than in the arm (171). Therefore, it is plausible that the 
elevated blood pressure experienced in the lower extremities results in attenuation in vascular 
reactivity and its homeostatic processes. 
It has also been documented that vascular dysfunction due to disease is limb-specific 
(34, 70, 123, 174), with the lower extremities exhibiting the higher degree of incidence, 
possibly due to gravity and the subsequently elevated orthostatic stress (53, 171). Therefore, 
it is important that additional research be conducted to further explore inherent vascular and 
metabolic limb differences. 
 
 
 
16 
 
Exercise and Limb-Specific Regulation of Muscle Blood Flow 
In addition to global cardiovascular improvements, exercise training provokes limb-
specific adaptations in vascular function according to the type of exercise performed (36, 73), 
and even improves vascular function in non-trained limbs (24, 39, 67, 68, 79, 215). DeSouza 
et al. (39) reported a significant improvement in endothelium-dependent vasodilation to 
acetylcholine in the arm after 3 months of aerobic exercise training. Studies from our 
laboratory extend these findings (215), demonstrating a significant, limb-specific 
improvement in BA FMD, but not in the deep femoral artery (DFA) of the leg after only 6 wk 
of isolated quadriceps muscle training. The improvement of BA vasodilation after single-leg 
knee extensor exercise training raises the question of how isolated limb training may produce 
improvements in vascular beds that do not experience direct, exercise-induced hyperemia. 
Others (39, 67, 96) have explored this topic, noting improved vasodilatory capacity in 
untrained limbs after whole body exercise training, which has been attributed to improved 
NO bioactivity.  
In humans, indirect measurements of blood flow in the arm during sympathomimetic 
infusion and orthostatic challenge (186) as well as cold stimuli (133) have demonstrated a 
similar degree of forearm vasoconstriction between leg-trained and sedentary subjects in 
response to the cold-pressor test (CPT). However, in view of the numerous previous studies 
in the area, it is somewhat surprising how few human studies have specifically assessed 
training-induced adaptations in sympathetic control of blood flow in trained and untrained 
limbs. 
 
Aging and Limb-Specific Regulation of Vascular Reactivity and Muscle Blood Flow 
Despite our growing understanding of vascular changes with age, several gaps in the 
literature and newly emerging concepts have clouded this area. Specifically, there appear to 
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be significant positional-, limb-, and site-specific differences in terms of vascular 
responsiveness that may blur the assimilation of some age-related studies (128, 216). Aged 
humans have consistently displayed a 20–30% attenuation in supine resting leg blood flow 
that has been attributed to 50% greater leg vascular resistance (42, 44, 118, 124). In addition 
to supine rest, aging appears to attenuate skeletal muscle blood flow in the leg at submaximal 
and maximal workloads (10, 86, 110, 145, 147). However, this age-related reduction in blood 
flow has not been documented in the human forearm (39, 88, 191). As yet unanswered is the 
question of whether the difference in resting leg blood flow between young and old humans is 
a consequence of posture, because leg blood flow measurements in human aging studies have 
always been made while the subject was supine? Also, is blood flow different between young 
and old subjects during upper extremity exercise? Furthermore, if arm blood flow and leg 
blood flow are measured in the same subjects, are the putative age-associated decreases in leg 
blood flow during exercise also seen in the arm? 
Recent data from Newcomer et al. (129) in resting subjects utilizing pharmacological 
interventions suggest that endothelial-dependent vasodilation in the leg is preserved with 
advancing age, whereas forearm endothelial-dependent vasodilation in the same aged 
subjects is reduced; although collected at rest, these data imply that endothelial dysfunction is 
not a likely mechanism for the age-related reduction in leg blood flow during exercise. 
Although there are no current data to identify a specific mechanism, the fact that leg blood 
flow and vascular conductance are reduced in specific conditions (supine and exercise) with 
age, whereas the arm is not affected, may be indicative of age-related and limb-specific 
changes in vessel structure or alterations in vascular tone. These findings may be mediated by 
factors such as sympathetic nervous system control (44, 97), endothelin (45), or other potent 
vasoconstrictors. The apparently nonuniform limb vascular response in healthy young 
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individuals certainly raises some important questions regarding possible limb-specific 
alterations that may take place in the aged vasculature.  
 
Limb-Specific Autonomic Control of the Vasculature  
In humans, similar degrees of responses have been exhibited in both the arm and leg 
during acute sympathetic activation (133, 186). In a recent study, Jacob et al. (87) evaluated 
adrenergic receptor sensitivity (change in vascular resistance) following sympathomimetic 
drug infusion (phenylephrine and isoproterenol) and the cold-pressor test (CPT) in the arm 
and leg of younger, normally active volunteers. This study reported a similar increase in local 
norepinephrine spillover in the arms and legs following the CPT, interestingly the calculated 
vascular resistance increased in the arm but decreased in the leg, suggesting a limb-specific 
end-organ response. However, during adrenergic drug infusions in the same subjects the arm 
demonstrated a greater sensitivity to phenylephrine and a lesser sensitivity to isoproterenol 
compared with the leg, suggesting that adrenergic-receptor differences cannot explain the 
paradoxical leg response. This study thus provides convincing evidence for similar 
sympathetic activation between limbs, but it provides no explanation for the dissociation 
between sympathetic activation and its functional correlate in the leg. 
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SPECIFIC AIMS AND HYPOTHESES 
 
Paper I 
Aim:   To determine the efficacy of an orally administered antioxidant cocktail on 
free radical concentration and evaluate the antioxidants effects on exercise-
induced brachial artery vasodilation in young healthy human subjects.  
Hypothesis #1:  The antioxidant cocktail will significantly attenuate the circulating free 
radical signal both at rest and as a consequence of exercise. 
Hypothesis #2:  In normal healthy subjects a large antioxidant-induced reduction in free 
radicals will actually attenuate exercise-induced-brachial artery 
vasodilation. 
 
Paper II 
Aim:  To examine whether sympathetically mediated vasoconstriction at rest and 
during acute exercise would differ between sedentary and exercise-trained 
subjects, and whether these differences would be global or limb-specific.  
Hypothesis #1:  Sympathetic vasoconstriction in response to the CPT at rest would be 
attenuated in both the arms and legs of exercise-trained subjects compared 
to sedentary controls.  
Hypothesis #2:  In sedentary subjects, acute exercise would attenuate sympathetically-
mediated vasoconstriction equally in the arms and legs. 
Hypothesis #3:  In the exercise trained subjects, sympatholysis would be limb-specific, 
such that acute exercise would attenuate sympathetically-mediated 
vasoconstriction to a greater degree in the trained legs compared to the 
relatively untrained arms. 
20 
 
 
Paper III 
Aim:  To investigate the limb-specific nature of conduit vessel flow-mediated 
dilation (FMD) and comprehensively evaluate the impact of both a 
mathematical and experimental normalization technique of the shear rate 
stimuli between two different vessels. 
Hypothesis #1:  The arm (brachial artery, BA) would exhibit a larger FMD than the leg 
(popliteal artery, PA) when expressed in traditional terms (% change) 
Hypothesis #2:  Experimental and mathematical normalization for shear rate would reveal 
a greater sensitivity (FMD) to a given stimulus level in the leg (PA) than 
the arm (BA). 
 
Paper IV 
Aim #1:  To characterize the post-ischemic cuff hyperemic response in the arm and 
leg of healthy subjects.  
Aim #2:  To characterize skeletal muscle metabolic activity and oxygenation during 
ischemia and elucidate their influence on muscle blood flow. 
Hypothesis #1:   Resting limb blood flow and post-ischemic hyperemia will be similar in 
the arm and the leg.  
Hypothesis #2:  When normalized for muscle mass, both the resting limb blood and the 
hyperemic response will be far greater in the arm.  
Hypothesis #3:  Utilizing multiparametric Nuclear Magnetic Resonance (NMR), we tested 
the additional hypothesis that the apparent difference in vascular control 
could be explained by differing skeletal muscle metabolic and/or 
oxygenation states between limbs. 
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Paper V 
Aim:  To determine the effect of aging on blood flow and vascular conductance 
during exercise in both the upper and lower extremities. 
Hypothesis #1:  There will be no difference young and old subjects in blood flow during sub-
maximal forearm exercise.   
Hypothesis #2:  The old group will exhibit an attenuated leg blood flow during sub-maximal 
leg exercise compared to young subjects. 
 
Paper VI 
Aim:  To evaluate the limb-specific effects of the aging process as it relates to 
structure, hyperemia, and vascular function of healthy older individuals. 
Hypothesis #1:  Intima-media thickness (IMT) will be greater in the PA than the BA in 
both young and old groups and the limb-specific IMT difference will be 
exaggerated with age.  
Hypothesis #2:  IR per unit of muscle mass will be attenuated in the lower leg compared to 
the arm and the IR limb-specific difference will be exaggerated with age.  
Hypothesis #3:  FMD, expressed in traditional terms (% diameter change), in both the BA 
of the arm and the PA of the leg will be attenuated in the aged group 
compared to the young group. 
Hypothesis #4:  FMD normalized for shear rate will not differ with age in the BA. 
However, in the PA, normalized FMD will reveal attenuated vascular 
function in the older group compared to young. 
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Paper VII 
Aim:  To extend previous findings of limb-vascular heterogeneity and the limb-
specific regulation of muscle blood flow, but with the added focus of 
determining the effect of sex.  
Hypothesis #1:  IR and FMD will differ between the BA and the PA of both the male and 
female groups, extending previous findings of limb-vascular 
heterogeneity. 
Hypothesis #2:  Based upon the purported beneficial antioxidant effects of estrogen on NO 
bioavailability, the impact of a reduced hemoglobin concentration ([Hb]), 
and smaller baseline vessel diameters in females, ischemic reperfusion and 
relative FMD will be more pronounced in the arms and legs of the female 
group. 
Hypothesis #3:  When initial vessel diameter and shear rate following cuff occlusion are 
taken in account (i.e. absolute FMD/shear rate) vascular function in the 
arms and legs will not be different between males and females. 
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MATERIALS AND METHODS 
SUBJECTS 
A total of 140 healthy subjects (122 young (23 ± 2 yrs) subjects (105 males and 17 young 
females) and 18 old (72 ± 2 yrs) subjects (16 males and 2 females)) participated in these 
studies. All subjects were nonsmokers, normotensive (<140/90 mmHg), and free of overt 
cardiovascular disease. Subjects were excluded from participation if they were taking any 
medications that would alter vascular responsiveness. Young female subjects were studied in 
the follicular phase (days 1-7) of their menstrual cycle. Three out of the 17 young female 
subjects were utilizing oral contraceptives. Old female subjects were post-menopausal and 
not on estrogen replacement therapy. Informed consent was obtained according to the 
University of California, San Diego, Human Subjects Protection Program requirements. 
Health histories and physical examinations were completed on all subjects. In addition, 
graded exercise tests were required for individuals over 40 years of age. All subjects reported 
to the laboratory in a fasted state (>4 hours postprandial) and had refrained from caffeine and 
exercise prior to the studies (>12 hours). All studies were performed in a thermoneutral 
environment. 
 
GENERAL PROCEDURES 
Single leg knee-extensor exercise (Papers II and V):  
The subject was seated on an adjustable chair with a cycle ergometer (model 828E; 
Monark Exercise AB, Vansbro, Sweden) placed behind them. Resistance was provided by 
friction on the flywheel, which was turned by the subject via a metal bar connected to the 
crank of the ergometer and a boot attached to the ankle of the subject. Sixty dynamic 
contractions of the knee-extensor muscles per minute were performed (1 Hz). Contractions of 
the quadriceps femoris muscle caused the lower part of the leg to extend from 90° to 170° 
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flexion. The momentum of the flywheel assisted in the return of the relaxed leg to the start 
position. Subjects exercised at work rates of their WRmax determined on the preliminary visit. 
Subjects were allowed sufficient practice during this pre testing to familiarize themselves 
with the exercise equipment, ensuring that each subject was comfortable with all testing 
procedures. This modality of exercise is excellent for Doppler studies because the muscles 
studied are major locomotors, are almost motionless during exercise, and good isolation of 
this muscle group has been documented (159, 160). Over the past five years we have 
constructed several versions of single leg knee-extensor ergometers and have published many 
studies utilizing them (109, 110, 162-165).  
 
Forearm handgrip exercise (Paper I and V):  
A single maximal voluntary contraction (MVC) was be established for subjects using a 
hydraulic handgrip dynamometer with an analog output (Rolyan Ability One, Germantown, 
WI, USA), and this MVC value was used to calculate an individual relative work rate. During 
the handgrip exercise, subjects were instructed to squeeze the dynamometer as quickly as 
possible, which limits the isometric contraction phase to less than 20% of the 2-sec duty cycle 
(0.5 Hz), resulting in a quasi dynamic exercise modality. 
 
Cold-pressor testing (CPT) (Paper II):  
Each CPT was preceded by at least 30 min of supine rest. For all CPT trials, sympathetic 
activation was accomplished through immersion of the foot in an ice water slurry (1-3 
degrees C) for 3 minutes, which has been well documented as a potent reflex stimulus 
capable of increasing muscle sympathetic nerve activity (130, 178, 179) and plasma 
norepinephrine levels in both arm and leg (87) without significantly elevating plasma 
epinephrine (13, 94, 122). 
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Flow-mediated vasodilation (FMD) (Papers III, IV, VI, and VII):  
Subjects lay supine and a pneumatic cuff (Hokanson, Bellevue, WA, USA) was 
positioned distal to the placement of the ultrasound Doppler probe (arm: upper arm proximal 
to the elbow, leg: lower right leg below/distal to the knee) visualizing the brachial artery of 
the arm and the popliteal artery of the leg (152). For leg trials, subjects lay supine on a 
gurney, modified to allow dorsal ultrasound Doppler access to the popliteal artery. After a 20-
min rest period, baseline measurements were made, and the cuff inflated to suprasystolic 
pressure (>250 mmHg) for 5 min. Full occlusion was documented by the loss of ultrasound 
spectra in vessels distal to the cuff. When appropriate, arm cuff was inflated to suprasystolic 
pressure (>250 mmHg) for a period of 30 to ≤ 120 s, to appropriately match the reactive 
hyperemia and subsequent shear rate observed in the leg FMD study (5 min occlusion).  
 FMD was calculated as the percent change (relative) or the absolute delta (absolute) 
from resting artery diameter to the largest diameter achieved during the 105 s of post-
inflation imaging. Consistent with the literature, the peak diameter was observed at 50–70 s in 
most subjects (31). All ultrasound vessel diameter measurements were evaluated during end 
diastole (corresponding to an R wave documented by the simultaneous ECG signal). 
 
Antioxidant supplementation (Paper I):  
All subjects received either an antioxidant cocktail or placebo supplementation in a 
randomized, double-blind balanced design. The formulation and timing of this antioxidant 
cocktail was the result of our pilot work employing vascular sampling and electron 
paramagnetic resonance (EPR) spectral analysis to document its efficacy in reducing free 
radical concentration, but restrained by the intent to not vastly exceed the common “over the 
counter” dosage for each individual antioxidant. Consequently, supplements were taken in 
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two doses separated by 30 minutes, with the first dose ingested two hours before the 
experimental protocol. The first dose consisted of 300 mg of  α-lipoic acid, 500 mg Vitamin 
C, and 200 I.U. Vitamin E, while the second included 300 mg α-lipoic acid, 500 mg Vitamin 
C, and 400 I.U. Vitamin E (water dispersible). Placebo microcrystalline cellulose capsules of 
similar taste, color, and appearance, and was likewise consumed in two similarly timed doses. 
 
MEASUREMENTS 
Ultrasound Doppler flowmetry (All Papers):  
An ultrasound Doppler (Logiq 7, GE Medical Systems, Milwaukee, Wisconsin, USA) 
equipped with a linear array mechanical sector transducer operating at an imaging frequency 
of 8-10 MHz was used to image arterial vessels of the arm and leg.  Vessel diameter and 
intima-media thickness (IMT) was determined at a perpendicular angle along the central axis 
of the scanned area, where the best spatial resolution was achieved. IMT was twice measured 
at rest, within close proximity (~0.05 cm), on the far wall, from the interface between blood 
and intima and the interface between media and adventitia, and then averaged (143). The 
brachial artery (BA) was insonated 4-8 cm proximal to the antecubital crease, medial to the 
biceps and brachii muscle. The popliteal artery (PA) was insonated in the popliteal fossa 
(hollow at the back of the knee) where it was optimally visualized. The common, superficial, 
and deep femoral arteries (CFA, SFA, and DFA respectively) were insonated distal to the 
inguinal ligament.  
 The blood velocity profile was obtained using the same transducer with a Doppler 
frequency of 5.0-6.7 MHz, operated at high-pulsed repetition frequency mode (2-25 kHz) 
with a depth of 0.5-3.5 cm in the BA and PA and 1.5-3.5 cm in the CFA, SFA, and DFA. 
Special care was taken to avoid aliasing, to ensure that probe position was stable, the 
insonation angle did not vary (60º), and that the sample volume was positioned in the center 
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of the vessel and adjusted to cover the width of the diameter and therefore the blood velocity 
 
distribution. Using arterial diameter and mean velocity (Vmean), blood flow was calculated as:  
Blood Flow (mL/min) = Vmean · π · (Vessel Diameter/2)2 · 60. Total blood flow (absolute and 
normalized for muscle mass) was quantified using the area under curve (AUC) for blood flow 
over time (ml or ml/100g), integrated with the use of commercially available software 
(SigmaPlot 8.0, Systat Software, Point Richmond, CA). Total blood flow (AUC) were 
integrated using the trapezoidal rule and was calculated as: ∑(yi(x(i+1) - xi) + (1/2)(y(i+1) - 
yi)(x(i+1) - xi)) 
 Shear stress has been identified as a mechanism that stimulates the vascular 
endothelium and results in subsequent vasodilation (144). However, as blood viscosity was 
not be measured, shear rate was calculated by using the equation (34, 215, 216): Shear rate 
(s-1) = 4· Vmean(cm/s) / Vessel diameter(cm). Cumulative shear rate was expressed using the 
area under the curve (s-1•s) for shear rate over time (1, 148), integrated with the use of 
commercially available software (SigmaPlot 8.0, Systat Software, Point Richmond, CA). 
Cumulative shear rate area under the curves was again integrated using the trapezoidal rule. 
 
 
Figure 1. An ultrasound Doppler screen 
capture illustrating the typical image and 
blood velocity spectra in the brachial 
artery following cuff-occlusion release. 
Note first two cardiac cycles of the 
Doppler signal are during cuff occlusion, 
followed by cuff release and subsequent 
hyperemia. TAMAX is peak veolocity 
(cm/s), TAMEAN is mean velocity 
(cm/s), Vol-Flow is blood flow (ml/min), 
VFDiam is arterial diameter (cm) 
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Multiparametric nuclear magnetic resonance (NMR) (Paper IV): 
These studies were carried out in a 4 Tesla, 46-cm internal bore, superconducting magnet 
(Magnex 4/60) interfaced to a Bruker Biospec NMR spectrometer. Muscle perfusion, 
intracellular oxygenation, and energy metabolism was studied simultaneously by rapidly 
interleaved acquisitions of saturation inversion recovery Arterial Spin Labeling (ASL) 
perfusion imaging, 1H spectroscopy of deoxymyoglobin, and 31P spectroscopy of the high-
energy phosphate metabolites (49). The subject’s appropriate limb was carefully positioned 
inside a 17 cm inner diameter transversal electromagnetic 1H transmit-and-receive volume 
coil, and an 8-cm diameter custom built 31P surface coil slid underneath the limb. 
 
Arterial Spin Labeling (ASL). A temporary perfusion map was extracted by summing the 
differences between successive pairs of images acquired at rest, 5 minutes of arterial 
occlusion, and 100 seconds following release. Multiple (2-3) regions of interest (ROIs) each 
with an area ~2-3 cm2 were traced within the lower leg and the forearm, randomly sampling 
the total area but carefully excluding voxels containing lipids or vessels. Identical ROIs were 
selected in all the images of the series, and perfusion (f) was calculated according to the 
equation (156): 
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where M stands for the image intensity in muscle ROI after slice-selective and nonselective 
inversion; T is the ASL time (0.82 s);  is the tissue/blood partition coefficient (0.9), and r1 is 
the muscle spin-lattice relaxation rate (0.66 s–1).We have previously described in detail the 
quantitative relationship between perfusion and the MRI signal (19, 60, 211, 212). 
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1H Deoxymyoglobin. After a 100-Hz line-broadening exponential multiplication and Fourier 
transformation, zero- and first-order phases of the deoxy-Mb spectrum were adjusted 
manually on an end-cuff acquisition. All FIDs of the series were processed using these same 
parameter settings. After automatic baseline correction (± 20 ppm), the deoxy-Mb peak of 
each spectrum was quantified by integration over 10 ppm. Fractional deoxy-Mb signal was 
determined by normalizing these data to the maximal deoxy-Mb spectra observed at the end-
cuff acquisition, assuming complete desaturation in 4-6 min (163, 199, 207). To appropriately 
account for the potential impact of muscle mass or limb myoglobin concentration, fractional 
deoxy-Mb was then normalized to limb muscle mass (deoxy-Mb (AU)/ muscle mass (100 g)). 
Myoglobin desaturation rate was determined by the slope of the linear portion of the deoxy-
Mb kinetic curve between 90-180 s during ischemic cuff-occlusion. 
 
31P Spectra of High-Energy Phosphates. The 31P FIDs were processed in a similar fashion to 
the 1H spectra, except for an 8-Hz line-broadening exponential multiplication. Inorganic 
phosphate (Pi) and phosphocreatine (PCr) integration limits were set to 5.6/3.5 ppm and 1.5/-
1.5 ppm, respectively. Muscle intracellular pH was calculated from the chemical shift (δ) 
between the Pi and PCr peaks (196): 
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δ+−
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Spin trapping and Electron Paramagnetic Resonance (EPR) spectroscopy (Paper I):  
EPR was performed on venous blood samples. Briefly, 4.5ml of venous blood was collected 
into a vacutainer that contained 1.5ml of the spin trap α-phenyl-tert-butylnitrone (PBN) 
(0.140mol/L). After centrifugation, the PBN adduct was extracted from the serum supernatant 
with toluene, and the adduct (200 µL) was pipetted into a precision-bore quartz EPR sample 
tube (Wilmad Ltd, UK) that had been flushed with compressed N2. EPR was performed at 21 
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°C using an EMX X-band spectrometer (Bruker, MA, USA) using commercially available 
software (Bruker Win EPR System, Version 2.11), with data processing blinded to 
experimental condition (achieved by coded numbering of samples). 
 
Heart rate (All Papers):  
Heart rate was recorded from a standard 3-lead ECG, an integral component of the Doppler 
system (Logiq 7, GE Medical Systems, Milwaukee, Wisconsin, USA). 
 
Noninvasive blood pressure (All Papers):  
During studies using the Doppler system, blood pressure was measured using radial 
tonometry (Biopac Systems NIBP 100A), which calculates systolic and diastolic and mean 
pressures derived from a pressure sensor placed directly above the radial artery. 
 
Tissue volume measurements (Papers II, and IV-VII):   
Forearm and lower leg circumferences (distal, proximal end, and one-third distal to the 
proximal end) and length (joint-to-joint) were measured to calculate tissue volume (92). 
Additionally, ventral (forearm, quadriceps) and dorsal (lower leg) skinfold measurements 
were taken to assess subcutaneous fat and allow the calculation of muscle volume for the 
quadriceps, lower leg and forearm (46, 92, 149).  
Muscle mass of the complete forearm (Papers II, and IV-VII) and lower leg (Papers 
II, and IV, VI, and VII) was calculated from the anthropometric assessment of muscle 
volume by multiplying by the density of muscle (1.06 g/cm3). On the basis of both an 
excellent agreement (forearm: ±5%, lower leg: ±2%) and a high correlation (forearm: r = 
0.91, lower leg: r = 0.92) between this method and dual energy X-ray absorbometry 
(Explorer; Hologic, Waltham, MA) documented previously in our laboratory for the forearm 
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(46) and recently (unpublished observations, (n=10)) in the lower leg, we applied the 
following regression equations to the anthropometrically determined values for the forearm 
and the lower leg: 
Forearm: muscle mass (anthropometric) (kg) · 1.155 - 0.24 = Muscle mass (kg) 
Lower Leg: muscle mass (anthropometric) (kg) · 1.0271 - 0.0064 = Muscle mass (kg). 
 
Thigh muscle volume (Paper II and V) was converted to quadriceps muscle mass with the use 
of the following equation: Thigh muscle volume (L) · 0.307 + 0.353 = thigh muscle mass.  
This anthropometrically determined quadriceps muscle mass, previously revealed to correlate 
highly with muscle mass assessed by computer tomography (r2 = 0.86), was corrected on the 
basis of this relationship with the following equation (149): Muscle mass 
(anthropometric)(kg) · 0.924-0.292 = quadriceps muscle mass (kg). It should be noted that 
these calculations do not remove the volume occupied by bone. 
 
Statistics:  
Statistics were performed using commercially available software (SigmaStat 3.10, Systat 
Software, Point Richmond, CA). Repeated-measures ANOVA, ANOVA, and Student's t-tests 
were used to identify significant changes in variables within and between age groups and 
limbs, with the Student-Newman-Keuls test used for post hoc analysis when a significant 
main effect was found. All group data are expressed as mean ± SE. Statistical significance 
was established at P < 0.05. 
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SUMMARY OF RESULTS 
Paper I 
Electron Paramagnetic Resonance (EPR) spectroscopy revealed a reduction in circulating free 
radicals following antioxidant administration at rest ( 98%) and as a consequence of exercise 
( 85%) (Figure 2).  
 
Plasma total antioxidant capacity and vitamin C both increased following the ingestion of the 
antioxidant cocktail, whereas vitamin E levels were not influenced by the ingestion of the 
antioxidants. Brachial artery vasodilation during submaximal forearm handgrip exercise was 
greater with the placebo (7.4 ± 1.8%) than with the antioxidant cocktail (2.3 ± 0.7%) (Figure 
3). 
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Figure 2. The alpha-phenyl-tert-
butylnitrone (PBN) electron 
paramagnetic resonance (EPR) 
spectroscopy data under the 
conditions of rest and following 
exercise with placebo and the oral 
antioxidant cocktail. Inlayed are 
representative individual examples 
of the PBN EPR spectra under each 
scenario. 
 
Figure 3. The effect of an oral 
antioxidant cocktail on change in 
brachial artery diameter in young 
healthy subjects at rest and at three 
submaximal levels of handgrip 
exercise (3, 6, and 9 kg at 0.5 Hz). 
Values for % change in brachial 
diameter are not exact and are 
displayed solely for reference 
purposes (right axis). * significantly 
different from the placebo condition. 
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Paper II 
At rest, the cold-pressor test (CPT) decreased vascular conductance similarly in the leg and 
arm of sedentary subjects (–33 ± 8% leg, –38 ± 6% arm) and cyclists (–34 ± 4% leg, –31 ± 
9% arm) (Figure 4), and during exercise CPT-induced vasoconstriction was blunted (i.e., 
Le
g 
va
sc
u
la
r 
co
n
du
ct
a
n
ce
 
(%
∆ )
-60
-40
-20
0
20
40
Rest
50% WRmax
-60
-40
-20
0
20
40
Ar
m
 
va
sc
u
la
r 
co
n
du
ct
an
ce
 
(%
∆ )
-60
-40
-20
0
20
40
-60
-40
-20
0
20
40
*
*
*
*
Sedentary Trained
 
sympatholysis) in both the leg and arm of both groups. However, the magnitude of 
sympatholysis was significantly different between the arm and leg of the sedentary group (–
47 ± 11% arm, –25 ± 8% leg), and it was less in the arm of cyclists (–28 ± 11%) than 
sedentary controls (Figure 5). 
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Figure 4. Changes in calculated 
vascular conductance from pre-CPT 
values during a 3-min CPT at rest 
(solid black bars) and during exercise 
at 50% of WRmax (solid gray bars) in 
leg (top) and arm (bottom) trials in 
sedentary and cyclist groups. Values 
are means ± SE. % , Percent change. 
*Significantly different from resting 
CPT trial, P < 0.05. 
Figure 5. "Magnitude of 
sympatholysis" in the leg and arm of 
the sedentary and cyclist groups, i.e., 
the calculated difference in vascular 
conductance changes between rest and 
exercise to the CPT. Values are means 
± SE. * Significantly different from 
leg (P < 0.05).  Significant difference 
between sedentary and cyclist groups, 
(P < 0.05). 
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Paper III 
The brachial artery (BA) revealed a smaller diameter and larger post-ischemic cumulative 
blood velocity (area under curve, AUC) than the popliteal artery (PA), a combination that 
resulted in an elevated post-cuff cumulative shear rate (AUC) in the BA (BA: 25419 ± 2896 
s-1•s; PA 8089 ± 1048 s-1•s, P < 0.05) (Figure 6A). Thus, when expressed in traditional terms 
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Figure 6. Brachial and popliteal shear rates and 
subsequent flow mediated dilations following 5 
minutes of cuff-occlusion in the brachial and 
popliteal arteries (Panel A and B, respectively), 
following reduced cuff duration in the brachial artery 
(Panel C and D), and FMD mathematically 
normalized for shear rate following conventional 5 
minute cuff occlusions (Panel E). * denotes  
significant difference between limbs (P < 0.05) 
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there was a tendency for the BA to have a greater FMD than the PA (6.5 ± 1.0% and 4.5 ± 
0.8%, respectively; P = 0.1) (Figure 6B). Due to an elevated shear rate in the BA compared to 
the PA for the 5 min cuffing experiment, average cuff duration during experimental shear rate 
matching protocols in the arm was significantly reduced from 5 min to 60 ± 9 s. Both 
individually and therefore on average, matching of shear rate was achieved (5 min cuff PA 
cuff-occlusion: 8089 ± 1048 s-1•s, BA reduced cuff duration: 8104 ± 1016 s-1•s) (Figure 6C). 
When shear rate was experimentally matched (PA: 4.5 ± 0.8%; BA: -0.4 ± 0.4%) (Figure 6D) 
or mathematically normalized; (PA: 6.8×10-4 ± 1.6×10-4 %∆/ s-1•s; BA: 2.5×10-4 ± 0.4×10-4 
%∆/ s-1•s) (Figure 6E) the PA revealed a greater FMD per unit of shear rate than the BA (P < 
0.05). 
 
Paper IV 
In absolute terms, both resting and cumulative blood flow (AUC)) over 105 s following cuff 
release was not different between the forearm and lower leg (Figure 7A). However, when 
appropriately expressed relative to muscle mass, blood flow was significantly different 
between limbs at rest (forearm: 10 ± 1; leg: 4 ± 0.5 ml/100g, P<0.05) and during ischemic 
reperfusion (IR) (forearm: 55 ± 4; leg: 17 ± 2 ml/100g AUC, P<0.05) (Figure 7B). To extend 
these limb-specific vascular findings and to examine potential contributing mechanisms, 6 
subjects were studied utilizing multiparametric nuclear magnetic resonance to simultaneously 
examine muscle perfusion (arterial spin labeling (ASL)), intracellular de-oxygenation 
(myoglobin proton spectroscopy), and muscle metabolism (phosphorous spectroscopy (31P)). 
Metabolic perturbation, muscle pH, and de-oxygenation rates during cuffing were not 
different between limbs. However, ASL (AUC) confirmed the resting blood flow differences 
between limbs (forearm: 16 ± 4; leg: 6 ± 1 ml/100g, P<0.05) which were maintained, albeit at 
a lesser degree, during IR (forearm: 47.1 ± 6.1; leg: 29.2 ± 2.9 ml/100g, P<0.05) (Figure 7C). 
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Paper V  
Quadriceps muscle mass was significantly different between young (2.1 ± 0.2 kg) and old 
subjects (1.6 ± 0.1 kg) (P<0.05). During exercise, blood flow and vascular conductance in the 
leg were attenuated in the old when expressed as blood flow per unit muscle mass for a given 
absolute workload or at a given relative exercise intensity (young, 1,523 ± 329; old, 1,340 ± 
157 ml·kg–1·min–1 at 40% WRmax) (Figure 8B). In contrast, aging did not affect forearm 
muscle mass or attenuate exercise blood flow or vascular conductance in the arm (Figure 8A)  
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Figure 7. Absolute limb blood flow at rest and 
following cuff release (panel A). Limb blood flow 
normalized for muscle mass at rest and following 
cuff release (panel B). Intramuscular perfusion at 
rest and following cuff release as measured by 
nuclear magnetic resonance imaging-based arterial 
spin labeling (NMRI ASL) (panel C). ‡ denotes 
significant difference between limbs at rest (P 
<0.05). * denotes significant difference between 
limbs following cuff release (AUC) (P < 0.05). 
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Figure 8. Effects of aging on blood flow per kilogram of forearm muscle mass (panel A) and of quadriceps muscle 
mass (panel B) during exercise across a series of submaximal absolute and relative workloads (handgrip at 0.5 Hz, 
knee-extensor 1Hz) in young and old subjects. * denotes significant difference between young and old 
 
 
Paper VI 
Intima-media thickness (IMT) measurements revealed a “thickening” in the popliteal artery 
(PA) compared to the brachial artery (BA) which was exaggerated with age (young: BA: 
0.028 ± 0.001 and PA: 0.046 ± 0.003, old: BA: 0.039 ± 0.002 and PA: 0.073 ± 0.005 cm; P < 
0.05) (Figure 9). IR revealed a similar pattern as IMT in terms of limb and age-related 
differences. 
In
tim
a-
 
M
ed
ia
 
Th
ic
kn
es
s 
(cm
)
0.00
0.02
0.04
0.06
0.08
0.10
Young
Old
POPLITEALBRACHIAL
*
*†
†
 
There was an age-related attenuation in both BA FMD (young: 7.4 ± 0.8%, old: 4.6 ± 0.6%; 
P < 0.05) and PA FMD (young: 5.5 ± 0.6%, old: 1.6 ± 0.5%; P < 0.05) (Figure 10A). 
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Figure 9. Brachial and popliteal artery 
intima-media thickness in young and old 
subjects. * denotes significant 
differences between limbs (P < 0.05). † 
denotes significant differences between 
young and old (P < 0.05).  
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Figure 10. Brachial and popliteal artery flow-mediated dilation in young and old subjects expressed as % change 
in diameter (panel A) and normalized for the shear rate stimulus (panel B). * denotes significant difference 
between brachial artery and popliteal artery (P < 0.05). † denotes significant difference between young and old 
groups (P < 0.05). Note the similar brachial artery flow-mediated dilation normalized for shear rate between 
young and old groups, whereas the same normalization for shear in the popliteal artery does not correct the 
attenuated dilation (panel B). 
However, when this % change was normalized for shear rate, only the PA FMD of the old 
group was still significantly attenuated (young: 10.0 ×10-4 ± 1.5 ×10-4, old: 5.8 ×10-4 ± 1.9 
×10-4 % ∆ / s-1•s) (P <0.05) (Figure 10B).  
 
 
Paper VII 
Between the sex groups, relative FMD (% diameter change) was significantly larger in the 
female group for the BA (male: 6.7 ± 0.6%, female: 8.7 ± 1.1%; P < 0.05) and was not 
statistically different in the PA (male: 4.4 ± 0.6%, female: 5.4 ± 0.8%) (Figure 11A). When 
relative FMD was normalized for the shear rate AUC, the PA of both limbs revealed no sex-
related differences (Figure 11C) (male group: PA: 8.3 × 10-4 ± 0.1 ×10-4 and BA: 3.8 × 10-4 ± 
0.3 × 10-4 % ∆ / s-1•s, P < 0.05; female group: PA: 7.5 × 10-4 ± 1.6 × 10-4 % ∆ / s-1•s and BA: 
3.5 × 10-4 ± 0.5 × 10-4 % ∆ / s-1•s, P < 0.05) (Figure 11C).  
With the statistically smaller resting diameters in the female group for both BA and 
PA, FMD was also assessed as an absolute change in diameter. Using this approach, there 
was no statistical difference both within and between limbs and sex groups (male group: BA: 
BRACHIAL POPLITEAL
Ve
ss
el
 
D
ia
m
e
te
r 
(%
 
Ch
a
n
ge
)
0
2
4
6
8
Young
Old
*
*†
A
BRACHIAL POPLITEAL
Ve
ss
el
 
%
 
Ch
an
ge
 
di
am
et
er
/s
he
ar
 
ra
te
 
(A
UC
)
(%
 
ch
an
ge
/ s
-
1 ⋅
 
s)
0.0000
0.0002
0.0004
0.0006
0.0008
0.0010
0.0012
0.0014
Young
Old
*
†
B
39 
 
0.027 ± 0.002 and PA: 0.027 ± 0.003 cm, female: BA: 0.027 ± 0.003 and PA: 0.024 ± 0.003 
cm) (Figure 11B). Consistent with the relative FMD, when absolute FMD was normalized for 
BRACHIAL POPLITEAL
Ve
ss
el
 
%
 
Ch
an
ge
 
di
a
m
e
te
r/s
he
a
r 
ra
te
 
(A
UC
)
(%
 
ch
an
ge
/ s
-
1 ⋅
 
s)
0.0000
0.0002
0.0004
0.0006
0.0008
0.0010
0.0012
Male 
Female
BRACHIAL POPLITEAL
Ve
ss
el
 
D
el
ta
 
Di
a
m
e
te
r/s
he
ar
 
ra
te
 
(A
UC
)
(cm
/ s
-
1 ⋅
 
s)
0
1e-6
2e-6
3e-6
4e-6
5e-6
6e-6
7e-6
Male 
Female
BRACHIAL POPLITEAL
Ve
ss
el
 
D
ia
m
et
e
r 
(%
 
Ch
an
ge
)
0
2
4
6
8
10
12
Male
Female
*
*
*
†
*
BRACHIAL POPLITEAL
Ve
ss
e
l D
e
lta
 
Di
am
et
er
 
(cm
)
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
Male
Female
*
*†
A B
C D
 
 
 
the shear rate AUC, the PA of both the male and female groups revealed a significantly 
greater FMD for a given shear rate than their respected BA’s (male group: PA: 5.0 × 10-6 ± 
0.8 ×10-6 and BA: 1.6 ×10-6 ± 0.1 ×10-6 cm / s-1•s, P < 0.05; female group: PA: 3.3 × 10-6 ± 
0.6 × 10-6 and BA: 1.2 × 10-6 ± 0.2 × 10-6 cm / s-1•s, P < 0.05) (Figure 11D). In contrast to the 
relative FMD/shear rate AUC, there was a sex-related difference in PA absolute FMD/ shear 
rate AUC (P < 0.05), but no sex-related difference in BA absolute FMD/Shear Rate AUC 
(Figure 11D).
Figure 11. Brachial and popliteal artery flow-mediated dilation (% diameter change (panel A) and absolute 
diameter change (panel B)) in male and female subjects. Flow-mediated dilation normalized for shear rate area 
under curve (% diameter change (panel C) and absolute diameter change (panel D)). * denotes significant 
difference between brachial artery and popliteal artery (P < 0.05). † denotes significant difference between male 
and female (P < 0.05). 
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DISCUSSION 
THE INFLUENCE OF OXIDATIVE STRESS ON VASCULAR FUNCTION DURING 
EXERCISE (Paper I) 
Pro- and Antioxidant Forces  
The delicate balance between pro- and antioxidant forces and the subsequent positive versus 
negative effects of free radicals is likely a crucial aspect of life (48). Low concentrations of 
free radicals appear to have both important mediating and modulating roles in cell signaling 
(48, 58, 126); however, without restraint higher levels of free radicals such as O2– can cause a 
wide spectrum of cellular damage, including lipid peroxidation, alteration of intracellular 
redox state, inactivation of enzymes, and damage to DNA. Consequently, there are numerous 
endogenous antioxidants that act as a defense system against oxidative stress. These 
antioxidants are generally divided into the nonenzymatic antioxidants (e.g. antioxidant 
vitamins) and the enzymatic antioxidants (e.g. SOD). Under normal circumstances the 
endogenous array of antioxidants combine to minimize, but, as evidenced in the current study 
by EPR spectroscopy, there is some normal background level of oxidative stress in vivo 
which is magnified by exercise (Figure 2). However, the acute ingestion of an antioxidant 
cocktail effectively ablated the blood-borne alkoxyl and alkyl radicals at rest and severely 
attenuated them following exercise (Figure 2). These EPR data certainly are indicative of the 
more "classical," although indirect, markers of peroxidation and provide clear evidence for 
peroxidative stress and its reduction with the antioxidant cocktail. The direct assessment of 
increased plasma total antioxidant capacity and vitamin C further validate this acute oral 
approach to tipping the balance away from pro-oxidant forces. With such an aggressive and 
clearly documented reduction in free radical concentration, the stage is set to determine the 
role of oxidative stress in the vascular response to exercise.  
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Exercise, Oxidative Stress, and Antioxidants  
In terms of the link between oxidative stress and vascular function, it is well accepted 
that free radicals likely limit vasodilation and blood flow by reducing NO bioavailability (54); 
however, it is also plausible that some free radicals and their end products increase 
vasodilation via their direct vasoactive properties (114). Clearly, the current data support the 
latter concept, because the large antioxidant-induced reduction in free radical concentration 
(Figure 2) resulted in a diminished vasodilatory response to exercise in the brachial artery 
(Figure 3). To our knowledge these are the first data to directly reveal that "unbalancing" the 
equation through a documented reduction in free radicals (and an increase in plasma 
antioxidants) in normal healthy subjects during exercise negatively impacts exercise-induced 
vasodilation (Figure 3). These data reveal a potentially important role for oxidative stress in 
provoking an appropriate vasodilation during exercise. We speculate that this attenuated 
exercise-induced vasodilation is likely the direct result of disturbing the natural balance 
between pro- and antioxidant forces. The downstream consequences of free radicals such as 
H2O2 and ONOO–, perhaps released in response to increased shear stress, may act as potent 
vasodilators (11), and as such possess the capacity to alter vascular responsiveness (114). 
Thus it is likely that the large and clearly documented reduction in free radical concentration 
following antioxidant administration (Figure 2) may have removed oxidative species, which 
possess some beneficial vasoactive properties, severely attenuating the exercise-induced 
brachial artery vasodilation following antioxidant ingestion. 
 
AUTONOMIC CONTROL OF MUSCLE BLOOD FLOW (Paper II) 
Limb-Specificity and Sympathetic Vasoconstriction at Rest and During Exercise 
The cold-pressor test (CPT) was utilized to provoke a profound reflex increase in 
sympathetic nerve activity (108), with subsequent changes in heart rate, arterial blood 
42 
 
pressure, and blood flow. Expression of sympathetic activation in response to the CPT has 
been well documented, with others demonstrating a robust (>300%) increase in muscle 
sympathetic nerve activity (131, 178) that does not differ between limbs (173, 181). 
Similarly, the CPT elevates venous norepinephrine levels to a similar degree 40–60% in both 
the arms and legs (26, 83, 87). These similarities in sympathetic activation between limbs set 
the stage to explore the end-organ translation of sympathetic activation into vasoconstriction, 
which to our knowledge has not been investigated utilizing ultrasound Doppler.  
Others have recognized vascular limb specificity in response to orthostasis (85), and 
sympathomimetics (87, 139). The current study supports the concept that sympathetically 
mediated vasoconstriction provoked by the CPT is expressed systemically at rest in the 
peripheral circulation (157), with no apparent selectivity of this response between limbs 
(Figure 4).  
Although sympathetic activation is fully expressed in resting muscle, recent studies 
indicate that this response may be blunted in the exercising limb, an event know as functional 
sympatholysis (197). In further support of this concept, we observed smaller changes in both 
arm and leg vasoconstriction during acute exercise compared with the resting CPT (Figure 4). 
These data extend recent observations by Koch et al. (97) that leg Q did not change when the 
CPT was applied to young subjects during upright cycling, although this study did not include 
a resting CPT trial for comparison. Thus, to our knowledge, this is the first report of a blunted 
sympathetic vasoconstriction in response to the CPT during limb-specific exercise in humans. 
 
Exercise Training and Sympathetic Vasoconstriction 
Although several cross-sectional (179, 190) and longitudinal (153, 183) studies have 
suggested that regular exercise training does not significantly change resting MSNA, we 
hypothesized that the actual expression of sympathetic activity would be lessened due to 
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limb-specific, training-induced changes in end-organ (i.e. α-adrenoreceptor) function. The 
present findings extend earlier findings, demonstrating that chronic exercise training does not 
alter resting sympathetically mediated vasoconstriction to either trained or untrained limbs in 
young, healthy subjects (Figure 4).  
Others have reported that exercise training results in a reduction in the expression of 
sympathetic nerve activity in muscle during acute knee-extensor (153) and handgrip (187) 
exercise, a response that appears to be limited to the trained limb (183). Thus one focus of the 
present study was to identify potential limb-specific responses to sympathetic 
vasoconstriction within both sedentary and exercise-trained subjects during acute exercise. 
Although leg Q and vascular conductance were significantly higher in cyclists than sedentary 
subjects during knee-extensor exercise (due to the higher absolute work rate), the CPT during 
exercise did not cause significant change in absolute leg vascular conductance in either group. 
These responses resulted in a similar calculated magnitude of sympatholysis between 
sedentary (–24 ± 8%) and cyclists (–22 ± 9%) (Figure 5). In contrast to the leg, the magnitude 
of vasoconstriction in the arm during exercise compared with rest differed according to 
training status. When vascular conductance changes were expressed as percent changes, the 
magnitude of sympatholysis in the arm was significantly greater in the sedentary group (–47 ± 
11%) than in the cyclists (–28 ± 11%) (Figure 5). From these results, it appears that 
vasoconstriction in the arm of the cyclists is somewhat less inhibited (i.e., more sympathetic 
vasoconstriction during exercise) than the sedentary group during exercise. We speculate that 
this response may be due to increased α-adrenergic sensitivity, similar to animal data 
demonstrating increased adrenergic vasoconstriction in the untrained (spinotrapezius) skeletal 
muscle of treadmill trained rats (104). Conceptually, this observed decrease in arm 
sympatholysis compared with the sedentary group may represent a training adaptation related 
to end-organ sensitivity designed to ensure optimal distribution of Q to the exercising legs, 
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and it may serve to prevent possible overperfusion of the arm and potential blood flow "steal" 
from the legs. However, further studies with measurements at multiple exercise intensities are 
needed to determine the mechanism responsible for this intriguing response in the relatively 
untrained limb of competitive cyclists. 
 
FLOW-MEDIATED DILATION AND ISCHEMIC REPERFUSION IN YOUNG HEALTHY 
INDIVIDUALS: ARE ALL LIMBS CREATED EQUAL? (Papers III and IV) 
Flow-Mediated Dilation (FMD) 
The FMD technique, first employed by Celermajer et al. (21), has emerged as a broadly 
applicable, non-invasive clinical tool to study endothelium-dependent peripheral artery 
vasomotion (22, 57, 195). In their original work and in the current study, a 5 minute or less 
cuff occlusion was employed with the aim of eliciting strictly a NO-dependent endothelial-
mediated response (47, 125). However, it was not until recently that the importance of the 
shear stress stimulus and its non-uniformity across subjects and studies was recognized, 
leading to a need to accurately manipulate or correct for this force (121, 148). Some have 
characterized shear stress as a peak attained after cuff release and used this variable to 
normalize FMD for the stimulus (34, 138). However, it has become increasingly apparent that 
the peak shear rate may not reflect the true nature of the shear stimulus. Therefore the area 
under the curve (AUC) for shear rate across time (s-1•s) has gained favor as the most 
appropriate approach to quantify the cumulative stimulus contributing to the vasodilatory 
response (148). In the current studies we adopted this approach and applied it accordingly, 
both experimentally and mathematically normalizing for shear rate AUC (Figure 6D and E).  
The importance of assessing shear rate and then incorporating any differences into the 
experimental design/analysis is highlighted by the finding that the popliteal artery (PA) 
exhibited a significantly reduced mean blood velocity profile after 5 minutes of cuff 
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occlusion when compared to the brachial artery (BA). This, combined with a larger diameter, 
lead to a much smaller shear rate in the PA compared to the BA (Figure 6A). To 
experimentally account for this shear rate difference, an additional protocol was performed in 
which the BA was cuffed for a shorter duration to lessen the ischemic reperfusion response 
and therefore reduce BA mean blood velocity following cuff release. As a result, shear rates 
were experimentally matched, and the shear stimulus was thus successfully normalized 
between the BA and PA (Figure 6C). With this approach the PA appears much more sensitive 
than the BA to a given shear rate (Figure 6D and E). However, these findings raise the 
possibility that the BA has a “shear rate threshold” below which a FMD response cannot be 
elicited. Nevertheless the fundamental aim of these studies was to examine limb-specific 
shear-mediated vasoreactivity in a scenario in which both the BA and PA received the same 
shear stimulus, and with this goal achieved the PA responded whereas the BA did not. 
Therefore, although a simple FMD assessment suggested that the lower extremities tend to 
have an attenuated vascular function compared to the upper extremities (Figure 6A), when 
the shear rate stimulus was appropriately incorporated experimentally (Figure 6D) or 
mathematically (Figure 6E) into the response, the PA of the lower extremities demonstrated 
greater vascular function than the BA of the upper extremities.  
 
Brachial artery and global vascular health. Although limb-specific vascular responses are 
gaining recognition (146, 214, 216), it has been commonplace for BA vasodilation (% 
change) measured by FMD to be used as an index of global vascular health (31, 201). 
However, the current data reveal that vascular responses to shear stimuli vary significantly 
across vessels of differing anatomic origin and therefore caution must be exercised when the 
vascular function of a conduit artery of a single limb is determined and the results translated 
to systemic vascular health.  
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Ischemic Reperfusion (IR) 
The role of muscle mass. The current data revealed no difference between absolute forearm 
and lower leg blood flow following cuff-occlusion (Figure 7A). The major dictator of muscle 
blood flow is metabolism at rest, as in this study, and metabolic demand is predominantly 
determined by muscle mass (42, 149). Accordingly, it is important to normalize limb blood 
flow to muscle mass when limbs of differing size are compared. When the large muscle mass 
differences of the forearm and lower leg were taken into account, blood flow per unit of 
muscle mass for the lower leg at both rest and following cuff release was significantly 
attenuated in comparison to the arm. This reveals, for the first time, an inherent difference in 
resting blood flow and IR between upper and lower extremities (Figure 7B and C). 
In addition to the skeletal muscle, other tissue that may promote hyperemia include 
adipose tissue, fascia, bone, and tendon, but their contributions during IR are, even as a 
whole, likely minimal (30, 151). Furthermore, skin perfusion, in a normothermic 
environment, does not significantly correlate with the conduit response during IR (182). 
Therefore with knowledge of the muscle mass to blood flow relationship, we are left 
speculating that either the muscle of the leg has a lower metabolic demand, leg muscle 
exhibits greater O2 extraction for a given volume of blood, or blood flow itself is directly 
limited either structurally or functionally and this results in greater O2 extraction.  
 
Between-limb metabolic heterogeneity. As a result of the integrated metabolic control 
mechanisms during tissue hypoxia, suprasystolic cuff occlusion creates dilation of 
downstream resistance vessels and provokes a post-cuff release hyperemia (198, 217). The 
reduction in substrate delivery and metabolite buildup during occlusion could significantly 
contribute to this metabolic vasodilation and induce a subsequent fall in downstream 
resistance (98, 167). Specifically, O2 demand and debt has long been implicated as a 
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Figure 12. Deoxy-myoglobin kinetics of the forearm (Panel A) and lower leg (Panel B) during cuff occlusion. 
The data for myoglobin desaturation rate (slope in shaded area) were assessed during the linear portion of the 
relationship from the point of conclusive myoglobin deoxygenation signal for 90 seconds during cuff-occlusion. 
AU, arbitrary units. 
 
regulator of blood flow (161, 217). In the current study, cuff occlusion applied to both limbs 
presents a uniform challenge that results in a reduction in arteriolar Po2 and the subsequent 
deoxygenation of hemoglobin during cuff occlusion contributes to vasodilation by 
stimulating red cell release of NO, or adenosine, prostaglandins, and NO release from the 
endothelium (51, 66, 120, 155). This progressive deoxygenation was supported in the current 
study by the intracellular assessment of deoxy-Mb, a marker of resting metabolic rate (161, 
163). However, as both the forearm and lower leg revealed the same rate of ischemically-
induced Mb desaturation, differences in O2 consumption do not readily explain the limb  
 
differences in IR (Figure 12). In fact, they support a similar basal O2 demand across the 
skeletal muscle of both the arm and the leg.  
 In combination, the similar rate of deoxy-Mb signal appearance during cuff occlusion 
(an index of muscle O2 consumption) and blood flow per unit of muscle mass collected both 
at rest and upon cuff release suggest the vascular differences (i.e. elevated blood flow) in the 
arm when compared to the leg may be a fundamental physiological differences in O2 
extraction. In light of these observations, the Fick equation (O2 consumption = blood flow × 
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(arterial – venous O2 concentration)) suggests O2 extraction must be nearly 3 fold different 
between limbs, with the greater extraction occurring in the leg.  
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This limb difference was remarkably consistent across scenario (rest and cuff release) and 
measurement approach (Doppler and ASL). Indeed, the only variance from the approximately 
3-fold greater levels in the arm than the leg being the ASL peak and AUC perfusion 
differences that were less clearly different, but were still significantly greater in the leg 
(Figure 13). This latter observation may be reconciled by both physiological and sampling 
heterogeneities in the muscle bed, and remains to be further assessed. This general 
observation of apparently greater O2 extraction in the lower leg may be attributed to a greater 
proportion of oxidative muscle fibers in the leg compared to the forearm (32). 
As expected, based upon previous reports (27), PCr hydrolysis in both the forearm 
and lower leg over the 5 minute cuff occlusion was minimal and revealed no measurable 
limb-specific metabolic perturbation. In addition, changes in muscle pH have been proposed 
to alter vascular tone as muscle pH can reduce intracellular Ca++ concentration and in turn 
cause vascular relaxation (141). However, again consistent with previous work in the arm 
(27), the short ischemic cuff occlusion did not stimulate a change in muscle pH in the muscle 
Figure 13. Ratio (fold difference) of arm to 
leg for rest, peak, and total (AUC) blood flow 
normalized for muscle mass (Doppler) and 
perfusion (ASL). * indicates significant 
difference from rest (P < 0.05). † indicates 
difference between Doppler and ASL (P < 
0.05). AUC, area under the curve; ASL, 
arterial spin labeling. 
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of the arm or leg. Therefore, the difference in limb-specific IR cannot be explained by 
differential metabolic perturbation, as examined by PCr breakdown or intramuscular pH. 
Although there are indeed changes to metabolic factors during cuff occlusion which 
are known to regulate blood flow (muscle oxygenation and [PCr]), the extent of these 
changes revealed no significant difference between limbs. Thus, the reduced IR in the leg 
(Figure 7B and C) suggests that the lower leg may have an attenuated response to these 
metabolic factors when compared with the forearm. This is in accordance with a previous 
report by Newcomer et al. (128) that found pharmacological and physiological vasodilatory 
stimuli elicited smaller relative blood flow and vascular conductance changes in the leg than 
the arm. It is also possible that a blunted responsiveness to vascular stimuli could explain the 
resting limb differences of a similar magnitude. 
 
Conduit muscle blood flow vs. muscle perfusion. The assessment of local skeletal muscle 
perfusion with ASL confirmed the contrasting IR exhibited by the forearm and lower leg 
already documented by Doppler measurements (Figure 7C). Additionally, with the 
combination of these two modalities, this study offers the unique opportunity to compare and 
contrast intramuscular hyperemia (ASL) and conduit blood flow (ultrasound Doppler) 
between limbs (Figure 14). Temporally, conduit vessel blood flow revealed an initial peak 
within 4-12 seconds in both the forearm and lower leg, in agreement with reports in the 
literature (134). The temporal response of perfusion was also similar between limbs, with 
both the forearm and lower leg revealing a consistent initial peak within the time frame of the 
conduit response, followed by an attenuated flow (most exaggerated in the lower leg), and 
then a true peak muscle perfusion after ~25-30 seconds (Figure 7C and 14). Reconciling the 
differences between the reperfusion kinetics in the conduit vessel and the muscle bed is  
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speculative, but perhaps the time delay in intramuscular perfusion could be, in part, explained 
by the vasodilatory cascade that occurs in the resistance vessels distal to the occlusion upon 
cuff release (144, 185), which may differ between limbs because of both lower leg structural 
and functional adaptations. Nonetheless, Figure 14 illustrates typical individual ASL and 
Doppler data collected from a subject that participated in both protocols and illustrates the 
similarities/differences between these responses and methods on an individual and group 
basis (Figure 7B and C), providing at least some initial support for the validity of the current 
unique observations. 
 
AGING (Papers V and VI) 
Structural and Functional Vascular Adaptations with Age. 
 Over time the human cardiovascular system undergoes many deleterious adaptations, and 
advancing age has therefore been proposed as a major risk factor for cardiovascular disease 
(101). Thus, determining the structural and functional vascular alterations with age can help 
provide mechanistic insight into the age-related increase in vascular disease risk. With the 
combination of both a structural analysis (IMT) and functional analyses (exercise blood flow, 
Figure 14. An example of the 
intramuscular perfusion and conduit 
blood flow profile in a subject that 
participated in both Doppler and ASL 
protocols.  
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IR and FMD) this study offers the somewhat unique opportunity to comprehensively evaluate 
limb-specific peripheral vascular characteristics and the effect of aging.  
Structurally, IM thickening with age has been documented in previous studies (81, 
135) as in this study (Figure 9). However this work has revealed that aging is accompanied 
by inherent structural adaptations that are exaggerated in the legs (Figure 9) and although this 
may not limit blood flow at rest, it may add to the attenuated blood flow response during both 
exercise (Paper V) and ischemic reperfusion (Paper VI). This aged-related attenuation in 
blood flow has certainly been well documented, particularly during the challenge of exercise 
(42, 110). However, it remains to be seen whether the structural changes in the vasculature 
are truly the cause of a decreased blood flow response with age. 
Functionally, advancing age has been typically associated with endothelial 
dysfunction (17, 205), and a progressive attenuation in nitric oxide synthase (eNOS) 
expression, impairment of the nitric oxide pathway, and elevated oxidative stress (2, 7, 184, 
194). Utilizing the FMD technique, the current data in the BA contradict the dogma of an 
age-related decline in endothelial function, showing a clear preservation of FMD when 
normalized to the shear stimulus (Figure 10B). However, the current data reveal that although 
the PA in the old experienced a similar post-cuff release shear rate to the young, it failed to 
yield a similar FMD whether or not normalized to the shear stimulus (Figure 10B). In 
combination, these findings suggest that the vascular dysfunction typically associated with 
age may be falsely identified in the arm where post-cuff shear rates seem to differ with age, 
but is clearly present in the leg, and at this site cannot be explained simply by a differing 
shear stimulus. This dissimilar shear to FMD response in the leg of the elderly group appears 
to support the concept of a predisposition to vascular dysfunction in the legs, but not the 
arms, of otherwise healthy older people. 
 
52 
 
The Effect of Age on Exercising Limb Blood Flow 
There were no age-associated differences in exercising forearm blood flow normalized for 
muscle mass, examined at both absolute and relative exercise intensities (Figure 8A). These 
findings are qualitatively similar to the only other study that has compared young and old arm 
blood flow associated with exercise, by Jasperse et al. (88), who documented no difference in 
postcontraction hyperemia between young and old subjects. In the leg, however, older 
subjects exhibited a lower leg blood flow than young subjects for a given absolute exercise 
intensity (Figure 8B). These data are in agreement with the majority of studies that have 
assessed absolute leg blood flow/vascular conductance during exercise in young and old 
subjects (10, 110, 145).  
In line with the findings of larger aging studies (63), the current subjects were found 
to have smaller quadriceps muscle mass with increasing age. Acknowledging the relationship 
between muscle mass and resting blood flow (42, 93), it is tempting to speculate that the 
smaller quadriceps muscle mass of the old may account for the attenuated exercising blood 
flow in this study. However, unlike rest, during exercise this would be a vast 
oversimplification of a complex process based on Henneman's (78) muscle recruitment 
theory. Specifically, during submaximal exercise, only a portion of the potentially active 
muscle mass is working (154), and thus at a given absolute work rate, leg blood flow is 
preferentially distributed to active muscle fibers (5, 106). Therefore, if leg blood flow in the 
aged population were represented as blood flow per unit muscle mass, this would be an 
overestimate because each absolute workload for the old subjects represents a greater 
percentage of their WRmax (Figure 8B, left). If the aged are working at a greater percentage of 
their WRmax, it is likely that these subjects recruit and perfuse a greater proportion of their 
quadriceps muscle mass to perform an absolute work rate (5, 106, 154). Consequently, when 
muscle masses differ between groups of subjects, work rates should be normalized to 
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percentage of WRmax and perfusion should be expressed per unit of muscle mass. When these 
normalizations were performed on the current data, the older subjects once again revealed an 
attenuated leg blood flow and vascular conductance at a given percentage of WRmax (Figure 
8B, right).  
 
Vascular Function and Vascular Disease Progression   
Several studies have now demonstrated that impaired endothelial function in both the 
coronary and peripheral circulation precedes the development of pathologies such as 
atherosclerosis (65, 75, 137, 170). Additionally, in those with atherosclerosis, the lower 
extremities appears to exhibit both a higher prevalence and a greater degree of impaired 
endothelial function than the upper extremities (4, 35). Therefore, in both young and old 
healthy subjects, the study of endothelial function in the upper and lower extremities suggests 
a greater predisposition and potential progression towards limb-specific vascular dysfunction 
and therefore susceptibility to vascular disease in these anatomically distinct locations. 
Indeed, the study of Angerer et al. (4) which investigated the effects of coronary artery 
disease on FMD in the BA and PA, found an attenuated PA FMD when compared to the BA 
in both patient and age-matched controls (≈ 50 yrs), with the greatest reduction in vascular 
function in the diseased patients. Unfortunately, this clinical study did not evaluate the shear 
stimulus, thus limiting accurate inference in the context of the present data. Nevertheless, the 
current data reveal an intriguing scenario, where both FMD and exercise hyperemia in the 
arm is preserved with age (Figures 8A and 10B), while the leg reveals a significant age-
related attenuation in these variables (Figures 8B and 10B). It is tempting to speculate that the 
age-related and limb-specific progression of vascular disease described elsewhere (4, 35) is 
the consequence of physical stresses over the life span which are exclusive to the leg 
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vasculature, such as larger hydrostatic and transmural forces as well as the continued stresses 
associated with daily locomotion (53, 115, 171). 
 
SEX DIFFERENCES IN VASCULAR FUNCTION (Paper VII) 
A Hormonal Milieu Effect on Flow-Mediated Dilation? 
Sex differences in FMD have been reported concomitantly with a greater post cuff hyperemia 
in nonmenopausal women when compared with age-matched men (112, 175). This effect has 
been explained by the positive effect of endogenous estrogens on the availability of nitric 
oxide (NO) (76), the principal vasodilator in shear-mediated vasodilation (125). Indeed, 
numerous studies have implicated estrogen as both a prostaglandin promoter and an 
antioxidant (6), protecting NO from degradation, and facilitating increased vasomotion (82, 
117, 140). In the present study, female BA relative FMD (% diameter change) was larger 
than that of the males, a finding that is consistent with the literature in suggesting augmented 
vascular endothelial-dependent vasodilation in females (figure 11A). However, sex 
differences in post-cuff release shear rate in the BA, the primary stimulus for endothelial-
dependent dilation, were observed in the present study. These findings conform to the 
stimulus-response paradigm for shear rate and endothelial-dependent vasodilation. 
Specifically, the lower shear exhibited by the male subjects in the BA elicited a smaller FMD 
response (figure 11A), however, after normalization for the shear stimulus (AUC), the sex-
related difference in both the BA and PA relative FMD was no longer evident (figure 11C). 
One explanation of the null sex-dependent improvement of vascular reactivity could be the 
fact that estrogens appear to primarily increase basal release rather than the stimulated NO 
release (172, 189). Indeed, it was demonstrated that the arterial vasocontrictive effect of NO 
synthase inhibitors was higher in women that in men despite these same vasodilating effect of 
acetylcholine between sexes (23, 192). However, although normalized for shear rate this 
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approach does not compensate for the mathematical bias associated with the smaller starting 
diameter exhibited by the females. In contrast, in the absolute FMD comparison, the shear 
rate AUC normalization rendered a similar result in the BA, but revealed a potential a gender 
difference in the PA. With this approach there is no longer a mathematical bias in favor of the 
small vessels of the females and may have unveiled a greater vascular sensitivity to shear 
stress in the lower legs of males.  
It must be noted that in the present study, we standardized study visits for women to 
coincide with days 1–7 of the menstrual cycle, when circulating estrogen is most likely to be 
lowest and similar to concentrations measured in men (76). Thus, it is likely that the 
predominant estrogen-mediated mechanisms underlying the present observations in women 
would have been exerted through the chronic, rather than acute, effects of estrogen on the 
vasculature. Studies by both Rogers and Sheriff (168) and New et al. (127) documented that 
estrogen significantly modulates vascular regulation independent of female sex. To that end, 
the study by Hashimoto et al. (76) demonstrated that within fluctuations of estrogen levels of 
the female menstrual cycle, the greatest endothelial-dependent vasodilation, assessed with the 
cuff-occlusion model, coincided with the end of the follicular phase where serum estradiol 
levels were highest. In addition, when estradiol levels were similar to concentrations 
measured in males (i.e. menses), vascular reactivity measured in the BA was similar to that of 
males. However, the data by Hashimoto et al. (76) was not normalized for the shear stimulus. 
Recognizing the acute effects of estrogen on blood flow regulation (168), it is unknown 
whether the results of Hashimoto et al. (76) may have been affected by an altered reactive 
hyperemia response at different times of the menstrual cycle. In light of this and the current 
data, it would be interesting to investigate the normalized FMD in females throughout the 
menstrual cycle to comprehensively elucidate the acute effects of estrogen on human vascular 
function. Despite the hypothesis of an increased vasodilation in the BA and/or PA of the 
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Figure 15. Baseline artery diameter and its influence on relative flow-mediated dilation (% diameter change) 
(Brachial: Panel A, Popliteal: Panel B) and absolute flow-mediated dilation (Brachial: Panel C, Popliteal: Panel D). 
 
female group, there appears to be no female-specific augmentation of peripheral artery 
vasodilation. In fact, there is evidence to the contrary with decreased vascular function in the 
PA of women when absolute FMD is normalized for shear rate AUC. 
 
Vessel Size and Flow-Mediated Dilation.  
 In general, caution should be exercised when comparing vessels of different sizes as there is 
a mathematical bias in favor of smaller arteries yielding a larger relative difference. However, 
in the current limb comparison for both sexes, because the PA has a larger starting diameter 
than the BA (handicapping % change in the PA), this mathematical bias can not explain the 
improved vascular responsiveness of the PA in comparison to the BA, but would, in fact, 
reduce the chance of this observation. Between sexes however, because there are significant 
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differences in starting diameters between males and females for the BA and PA, definitive 
conclusions cannot be drawn from the relative diameter changes data. In the present study, as 
in other studies (21, 89, 102, 127), the flow-induced change in artery diameter is inversely 
related to the basal value of the diameter when expressed in percent change from baseline 
(relative FMD) in both the BA and PA (figure 15A and 15B). This supports the idea that 
larger arteries show a less convincing relative vasodilation compared to smaller arteries. 
Correlation analyses of the flow-induced change in artery diameter expressed as an absolute 
change from basal diameter reveals no such relationship (figure 15C and 15D). This supports 
the latter analytical approach as the most unbiased interpretation when considering vessels of 
different size. Thus, definitive statements concerning differences in endothelial function 
between the sexes need to be carefully interpreted if compared solely in relative terms.  
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CONCLUSIONS 
Inherent limb differences appear to exist, and to different extents in varied populations. These 
studies have elucidated several underlying mechanisms defining vascular heterogeneities, all 
of which are important for understanding skeletal muscle blood flow and vascular control 
mechanisms in not only a healthy population, but also in diseased populations that may to 
exhibit limb-specific vascular dysfunction. 
 
I. This study demonstrates that the brachial artery of healthy subjects vasodilates less 
following the ingestion of an antioxidant cocktail during submaximal exercise, despite 
similar or slightly elevated shear rates. This suggests that an antioxidant-induced 
reduction in oxidative stress, as supported by blood EPR measurements, negatively 
impacts the natural balance between pro- and antioxidant forces that exists in normal 
healthy subjects. This reveals a reliance on free radical-mediated vasodilation, most 
likely induced by the increased oxidative stress of exercise per se (increased metabolic 
rate) or the shear-induced release of free radicals by the vascular endothelium. 
 
II. This study reveals that sympathetically-mediated vasoconstriction in response to the CPT 
at rest is not limb-specific or affected by exercise training status, and that acute exercise 
effectively blunts sympathetic vasoconstriction (i.e. sympatholysis) in both trained and 
untrained limbs. However, there was a reduced magnitude of sympatholysis in the arm of 
predominantly leg-trained individuals, exemplifying the systemic vascular effects of 
exercise training that may optimize blood flow distribution to meet limb-specific 
demand. 
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III. This study highlights the importance of both quantifying and accounting for the shear 
stimulus in FMD studies. Without either experimental or mathematical normalization of 
this important variable, clear limb-specific differences in endothelium-dependent 
vasoreactivity would not have been unveiled. With this approach, the present data 
suggest that the PA in a healthy, young, male population exhibits an enhanced vascular 
response to a given shear stimulus when contrasted with the BA. 
 
IV. There is a clear and robust difference in skeletal muscle blood flow between limbs that is 
maintained from rest to IR. Although the exact mechanism for this limb-specific 
difference has not been completely determined, many potential mechanisms have been 
excluded, leading to the conclusion that observed responses may be due in part to 
difference in O2 extraction between the skeletal muscle of the arm and leg. However, it is 
still unclear whether this differing O2 extraction paradigm is the consequence or cause of 
the limb-specific difference in the control of skeletal muscle blood flow.  
 
V. During single-leg knee extensor exercise, older subjects exhibit a reduced leg blood flow 
that was still evident when differences in muscle recruitment were taken into account. In 
contrast, arm blood flow during forearm exercise is not influenced by age and was not 
complicated by differences in work rate. Therefore, age-associated changes in blood flow 
during exercise are not uniform across limbs. 
 
VI. The structural analysis of vascular IMT across limbs revealed an age-related thickening 
of peripheral conduit arteries that is more pronounced in the legs. FMD data reveal that 
the brachial artery of older healthy subjects exhibits a preserved endothelial-dependent 
vascular reactivity when shear is taken into account. In contrast, this does not appear to 
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be the case in the popliteal artery and, in combination with structural alterations, may be 
indicative of a limb-specific and age-related progression towards vascular dysfunction in 
the legs that precedes clinical signs of vascular disease. 
 
VII. The present investigation extends previous findings in young, healthy males of greater 
endothelial-dependent vascular reactivity in the lower compared to the upper extremities 
to females. It is also concluded that basal vessel diameter and shear rates influence the 
magnitude of relative flow-mediated vasodilation and that the sex differences previously 
reported could be the consequence of a mathematical bias and differences in shear 
stimulus rather than a sex-related physiological difference. These vascular characteristics 
are essential to the appropriate interpretation and thus should be taken into account when 
comparing the vascular responsiveness of men and women. Therefore, when the most 
rigorous analysis for these conditions, absolute FMD normalized for shear rate, is 
applied the BA does not exhibit a difference between the sexes, whereas, the PA displays 
attenuated function in females. 
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